- Home
- COOK vs OABI Comparison
COOK vs OABI Comparison
Compare COOK & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COOK
- OABI
- Stock Information
- Founded
- COOK 1985
- OABI 2012
- Country
- COOK United States
- OABI United States
- Employees
- COOK N/A
- OABI N/A
- Industry
- COOK Wholesale Distributors
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- COOK Consumer Discretionary
- OABI Health Care
- Exchange
- COOK Nasdaq
- OABI Nasdaq
- Market Cap
- COOK 406.5M
- OABI 429.6M
- IPO Year
- COOK 2021
- OABI N/A
- Fundamental
- Price
- COOK $2.55
- OABI $3.21
- Analyst Decision
- COOK Buy
- OABI Strong Buy
- Analyst Count
- COOK 5
- OABI 4
- Target Price
- COOK $4.10
- OABI $9.00
- AVG Volume (30 Days)
- COOK 178.8K
- OABI 483.2K
- Earning Date
- COOK 03-06-2025
- OABI 11-12-2024
- Dividend Yield
- COOK N/A
- OABI N/A
- EPS Growth
- COOK N/A
- OABI N/A
- EPS
- COOK N/A
- OABI N/A
- Revenue
- COOK $598,914,000.00
- OABI $20,409,000.00
- Revenue This Year
- COOK $1.02
- OABI N/A
- Revenue Next Year
- COOK $4.69
- OABI $78.61
- P/E Ratio
- COOK N/A
- OABI N/A
- Revenue Growth
- COOK 3.17
- OABI N/A
- 52 Week Low
- COOK $1.97
- OABI $3.16
- 52 Week High
- COOK $3.97
- OABI $6.55
- Technical
- Relative Strength Index (RSI)
- COOK 48.48
- OABI 31.99
- Support Level
- COOK $2.15
- OABI $3.16
- Resistance Level
- COOK $2.47
- OABI $3.37
- Average True Range (ATR)
- COOK 0.11
- OABI 0.14
- MACD
- COOK 0.04
- OABI -0.03
- Stochastic Oscillator
- COOK 93.96
- OABI 7.55
About COOK Traeger Inc.
Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.